twitter

Wednesday 18 October 2017

Synthetic approaches to developing new pharmacological modulators for P2X7 receptors (STOKES_U18DTP2)

WHERE TO APPLYCONTACTSAVE TO FAVORITES SHOW ON MAP ORGANISATION/COMPANY University of East Anglia RESEARCH FIELD Pharmacological sciences RESEARCHER PROFILE First Stage Researcher (R1) APPLICATION DEADLINE 27/11/2017 23:00 - Europe/London LOCATION United Kingdom › Norwich TYPE OF CONTRACT Other JOB STATUS Other OFFER STARTING DATE 01/10/2018 Ginseng is a medicinal herb used in traditional medicine in Asia for thousands of years. In traditional Chinese medicine practices it is an “all healing” tonic thought to have many beneficial effects including stimulating the immune system. The pharmacologically active constituents of ginseng are known as ginsenosides and there are over 30 different chemicals present. We recently discovered that several protopanaxadiol ginsenosides, including the major in vivo metabolite (ginsenoside CK) act as positive allosteric modulators of the P2X7 ion channel. The action of ginsenosides reduces the concentration of the ligand ATP required for channel activation and enhances downstream signalling pathways including an increase in macrophage cell death. This action of ginsenoside CK on P2X7 may underlie some of the reported immune boosting actions of ginsenosides in vivo. In this PhD project we will explore the structure-activity relationship of the interaction between protopanaxadiol ginsenosides and P2X7. We have a basic idea of which chemical groups are required for activity at this ion channel (Helliwell et al, 2015; British Journal of Pharmacology) and will explore this further using two approaches. The first is a semi-synthetic chemistry approach in collaboration with an experienced medicinal chemist Professor Ganesan. The second is a biosynthetic approach in collaboration with an experienced plant biologist Professor Anne Osbourn (JIC). During this project we will design and generate novel analogues of ginsenosides to test for improved activity at the P2X7 receptor. The student will be trained in a number of medicinal chemical and biological techniques in different laboratories gaining a unique expertise in natural product pharmacology and drug discovery. This project has been shortlisted for funding by the Norwich Biosciences Doctoral Training Partnership (NRPDTP). Shortlisted applicants will be interviewed as part of the studentship competition. Candidates will be interviewed on either the 9th, 10th or 11th January 2018. The Norwich Biosciences Doctoral Training Partnership (NRPDTP) offers postgraduates the opportunity to undertake a 4 year research project whilst enhancing professional development and research skills through a comprehensive training programme. You will join a vibrant community of world-leading researchers. All NRPDTP students undertake a three month professional internship (PIPS) during their study. The internship offers exciting and invaluable work experience designed to enhance professional development. Full support and advice will be provided by our Professional Internship team. Students with, or expecting to attain, at least an upper second class honours degree, or equivalent, are invited to apply. For further information and to apply, please visit our website: http://www.biodtp.norwichresearchpark.ac.uk Funding notes Full Studentships cover a stipend (RCUK rate: £14,553pa – 2017/8), research costs and tuition fees at UK/EU rate, and are available to UK and EU students who meet the UK residency requirements. Students from EU countries who do not meet the UK residency requirements may be eligible for a fees-only award. Students in receipt of a fees-only award will be eligible for a maintenance stipend awarded by the NRPDTP Bioscience Doctoral Scholarships, which when combined will equal a full studentship. To be eligible students must meet the EU residency requirements. Details on eligibility for funding on the BBSRC website: http://www.bbsrc.ac.uk/web/FILES/Guidelines/studentship_eligibility.pdf